Innovative platforms for oral microencapsulation formulation and drug analytical techniques for anti-diabetics
dc.contributor.author | Gedawy, Ahmed Abou Bakr Gaber | |
dc.contributor.supervisor | Crispin Dass | en_US |
dc.contributor.supervisor | Hani Al-Salami | en_US |
dc.date.accessioned | 2020-12-07T04:31:44Z | |
dc.date.available | 2020-12-07T04:31:44Z | |
dc.date.issued | 2020 | en_US |
dc.identifier.uri | http://hdl.handle.net/20.500.11937/81966 | |
dc.description.abstract |
This thesis is divided into two main sections. The first section is about developing of silicon-based pharmaceutical platform that was used to encapsulate an anti-diabetic agent (metformin). These developed microcapsules were then characterised in terms of drug content, encapsulation efficiency, flow properties and microscopical examination. The second section is about development and validation of a new HPLC analytical method for the detection and quantification of metformin and two other anti-diabetic agents that belong to sulfonylureas. | en_US |
dc.publisher | Curtin University | en_US |
dc.title | Innovative platforms for oral microencapsulation formulation and drug analytical techniques for anti-diabetics | en_US |
dc.type | Thesis | en_US |
dcterms.educationLevel | MPhil | en_US |
curtin.department | School of Pharmacy and Biomedical Sciences | en_US |
curtin.department | Biotechnology and Drug Development Research Laboratory | en_US |
curtin.department | Curtin Health Innovation Research Institute | en_US |
curtin.accessStatus | Open access | en_US |
curtin.faculty | Health Sciences | en_US |
curtin.contributor.orcid | Gedawy, Ahmed Abou Bakr Gaber [0000-0003-1568-5455] | en_US |